- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
HHS Secretary Kathleen Sebelius Resigns
HHS Secretary Kathleen Sebelius has resigned her post barely a week after the close of the tumultuous initial open-enrollment period for the healthcare reform law's insurance exchanges.
HHS Secretary Kathleen Sebelius has resigned her post barely a week after the close of the tumultuous initial open-enrollment period for the healthcare reform law's insurance exchanges.
The six-month signup period was plagued by technology problems that initially thwarted consumers' attempts to enroll in coverage. But it closed with a surge of interest that ultimately saw the Obama administration top its goal of 7 million enrollments. The tally has grown to 7.5 million, Sebelius testified during a budget hearing on Capitol Hill just hours before her resignation was reported.
“Maybe this is a good point to make the transition, given that the enrollment for 2014 is just finished,” said Paul Ginsburg, a health policy expert at the Price School of Public Policy at the University of Southern California. “It finished on a high note despite all the problems experienced since the beginning. If a change was going to be made, this seems like a pause to make a change like that.”
Read the full story here: http://bit.ly/1n0868Q
Source: Modern Healthcare
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
